東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Epidermal growth factor." ]

切換: 標籤 | MARC模式 | ISBD

Guide to targeted therapies = treatm...

Cappuzzo, Federico.

FindBook

Google Book

Amazon

博客來

Guide to targeted therapies = treatment resistance in lung cancer /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Guide to targeted therapies/ by Federico Cappuzzo.
其他題名:	treatment resistance in lung cancer /
作者:	Cappuzzo, Federico.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	vii, 67 p. :ill., digital ;24 cm.
內容註:	Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options -- Conclusions.
Contained By:	Springer eBooks
標題:	Lungs - Cancer -
電子資源:	http://dx.doi.org/10.1007/978-3-319-20741-4
ISBN:	9783319207414

Guide to targeted therapies = treatment resistance in lung cancer /
Cappuzzo, Federico.

Guide to targeted therapiestreatment resistance in lung cancer /[electronic resource] :by Federico Cappuzzo. - Cham :Springer International Publishing :2015. - vii, 67 p. :ill., digital ;24 cm.

Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options -- Conclusions.

This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.

ISBN: 9783319207414

Standard No.: 10.1007/978-3-319-20741-4doiSubjects--Topical Terms:

2017391
Lungs
--Cancer

LC Class. No.: RC280.L8

Dewey Class. No.: 616.9942406

Guide to targeted therapies = treatment resistance in lung cancer /
LDR:01594nmm a2200313 a 4500 001 2013636
003 DE-He213
005 20160408161554.0
006 m d
007 cr nn 008maaau
008 160518s2015 gw s 0 eng d
020 $a 9783319207414 $q (electronic bk.)
020 $a 9783319207407 $q (paper)
024 7 $a 10.1007/978-3-319-20741-4 $2 doi
035 $a 978-3-319-20741-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.9942406 $2 23
090 $a RC280.L8 $b C249 2015
100 1 $a Cappuzzo, Federico. $3 2107073
245 1 0 $a Guide to targeted therapies $h [electronic resource] : $b treatment resistance in lung cancer / $c by Federico Cappuzzo.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2015.
300 $a vii, 67 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options -- Conclusions.
520 $a This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
650 0 $a Lungs $x Cancer $x Treatment. $3 2017391
650 0 $a Epidermal growth factor. $3 2107074
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Oncology. $3 751006
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-20741-4
950 $a Medicine (Springer-11650)